Cargando…

Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021

Detalles Bibliográficos
Autores principales:	Learned, Christine, Alsukait, Sara, Deverapalli, Sandhya, Elliott, Erika, Moody, Katherine, Sobell, Jeffrey, Konnikov, Nellie, Ortega, Melissa, Rosmarin, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043660/ https://www.ncbi.nlm.nih.gov/pubmed/35497638 http://dx.doi.org/10.1016/j.jdin.2022.03.010

Ejemplares similares

Erythema nodosum-like panniculitis associated with immune checkpoint inhibitor therapy: Two cases reporting a rare cutaneous adverse event
por: Pach, Jolanta, et al.
Publicado: (2021)

Drug repositioning prediction for psoriasis using the adverse event reporting database
por: Ko, Minoh, et al.
Publicado: (2023)

Pattern of adverse events induced by aflibercept and ranibizumab: A nationwide spontaneous adverse event reporting database, 2007–2016
por: Ha, Dongmun, et al.
Publicado: (2019)

Signal Detection of Adverse Events Following Pneumococcal Vaccines from the Korea Adverse Event Reporting System Database, 2005–2016
por: Kim, Kwan Soo, et al.
Publicado: (2020)

Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events
por: Yu, Yue, et al.
Publicado: (2016)

Signal Detection for Cardiovascular Adverse Events of DPP-4 Inhibitors Using the Korea Adverse Event Reporting System Database, 2008–2016
por: Yi, Hyemin, et al.
Publicado: (2019)

Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017
por: Dores, Graça M., et al.
Publicado: (2019)

Monitoring adverse social and medical events in public health trials: assessing predictors and interpretation against a proposed model of adverse event reporting
por: Moody, Gwenllian, et al.
Publicado: (2019)

Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
por: Noda, Aoi, et al.
Publicado: (2020)

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
por: Kato, Yamato, et al.
Publicado: (2015)

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)
por: Su, Si, et al.
Publicado: (2023)

Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
por: Negishi, Akio, et al.
Publicado: (2020)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
por: Han, Nayoung, et al.
Publicado: (2021)

Assessing taxane-associated adverse events using the FDA adverse event reporting system database
por: Lao, Dong-Hui, et al.
Publicado: (2021)

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
por: Yamashiro, Kaito, et al.
Publicado: (2022)

Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

Completeness of adverse drug reactions reports of the Saudi adverse event reporting system
por: Alshammari, Thamir M., et al.
Publicado: (2015)

Assessment and monitoring of biologic drug adverse events in patients with psoriasis
por: Hanley, Tessa, et al.
Publicado: (2016)

Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019
por: Wei, Shaokui, et al.
Publicado: (2021)

Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
por: Sonawane, Kalyani B., et al.
Publicado: (2018)

Topiramate-related adverse events: Pattern and signals in the Korea Adverse Event Reporting System, 2010-2017
por: Choi, Junyeong, et al.
Publicado: (2020)

Visualization of Kinase Inhibition-Related Adverse Events Using the Japanese Adverse Drug Event Report Database
por: Mizuno, Takahito, et al.
Publicado: (2021)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

Three aspects of acupuncture-related adverse events: Issues around the reporting of acupuncture-related adverse events
por: Kim, Tae-Hun, et al.
Publicado: (2023)

A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
por: Zou, Shu-peng, et al.
Publicado: (2023)

WITHDRAWN: A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products
por: Rose, Jessica, et al.
Publicado: (2021)

Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database
por: Nagai, Junko, et al.
Publicado: (2021)

Characteristics and Comparison of Adverse Events of Coronavirus Disease 2019 Vaccines Reported to the United States Vaccine Adverse Event Reporting System Between 14 December 2020 and 8 October 2021
por: Zou, Chenyu, et al.
Publicado: (2022)

Drug-Induced QT Prolongation and Torsade de Pointes in Spontaneous Adverse Event Reporting: A Retrospective Analysis Using the Japanese Adverse Drug Event Report Database (2004–2021)
por: Uchikawa, Mayu, et al.
Publicado: (2022)

Mucocutaneous adverse events to immune checkpoint inhibitors
por: Muhaj, Fiorinda, et al.
Publicado: (2023)

Standardizing adverse drug event reporting data
por: Wang, Liwei, et al.
Publicado: (2014)

Seasonal and Geographic Variation in Adverse Event Reporting
por: Marrero, Osvaldo, et al.
Publicado: (2016)

Chloroquine: Psychiatric adverse events: case report
Publicado: (2020)

Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021
por: Moro, Pedro L., et al.
Publicado: (2022)

Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
por: Toki, Tadashi, et al.
Publicado: (2018)

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
por: Duprey, Matthew S., et al.
Publicado: (2019)

Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System
por: Jeon, Minji, et al.
Publicado: (2021)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
por: Subedi, Smriti, et al.
Publicado: (2019)

Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database
por: Iarikov, Dmitri, et al.
Publicado: (2015)

Three‐Component Mixture Model‐Based Adverse Drug Event Signal Detection for the Adverse Event Reporting System
por: Zhang, Pengyue, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jpk1llicsgv4glv5kln2k2482v